The challenges of establishing adequate capacity for SARS-CoV-2 testing.
作者信息
Smith David W
机构信息
University of Western Australia, Perth, WA.
PathWest Laboratory Medicine WA, Perth, WA.
出版信息
Med J Aust. 2020 Jun;212(10):457-458. doi: 10.5694/mja2.50610. Epub 2020 May 13.
Abstract
摘要
相似文献
1
The challenges of establishing adequate capacity for SARS-CoV-2 testing.建立足够的新冠病毒检测能力所面临的挑战。
Med J Aust. 2020 Jun;212(10):457-458. doi: 10.5694/mja2.50610. Epub 2020 May 13.
2
"The Art of War" in the Era of Coronavirus Disease 2019 (COVID-19).2019冠状病毒病（COVID-19）时代的《战争艺术》
Clin Infect Dis. 2020 Nov 19;71(16):2215-2217. doi: 10.1093/cid/ciaa229.
3
Diagnosis and Management of First Case of COVID-19 in Canada: Lessons Applied From SARS-CoV-1.加拿大首例 COVID-19 病例的诊断与管理：从 SARS-CoV-1 中吸取的经验教训。
Clin Infect Dis. 2020 Nov 19;71(16):2207-2210. doi: 10.1093/cid/ciaa227.
4
Testing recommendation for COVID-19 (SARS-CoV-2) in patients planned for surgery - continuing the service and 'suppressing' the pandemic.针对计划接受手术的新冠病毒（SARS-CoV-2）感染患者的检测建议——持续提供服务并“抑制”疫情。
Br J Oral Maxillofac Surg. 2020 Jun;58(5):503-505. doi: 10.1016/j.bjoms.2020.04.014. Epub 2020 Apr 13.
5
SARS CoV-2 Detection From Upper and Lower Respiratory Tract Specimens: Diagnostic and Infection Control Implications.严重急性呼吸综合征冠状病毒2型在上、下呼吸道标本中的检测：对诊断和感染控制的意义
Chest. 2020 Nov;158(5):1804-1805. doi: 10.1016/j.chest.2020.07.061.
6
Pandemic SARS-CoV-2 laboratory preparedness in India: An opportunity beyond diagnostics.印度应对新冠病毒大流行的实验室准备工作：超越诊断的机遇。
Indian J Med Res. 2020 May;151(5):495-496. doi: 10.4103/ijmr.IJMR_1548_20.
7
Temperature and the difference in impact of SARS CoV-2 infection (COVID-19) between tropical and non-tropical regions in Taiwan.台湾热带与非热带地区的温度及新型冠状病毒感染（COVID-19）影响的差异
Travel Med Infect Dis. 2020 Jul-Aug;36:101790. doi: 10.1016/j.tmaid.2020.101790. Epub 2020 Jun 13.
8
Neurological manifestations in COVID-19 caused by SARS-CoV-2.由严重急性呼吸综合征冠状病毒2（SARS-CoV-2）引起的2019冠状病毒病（COVID-19）中的神经表现。
CNS Neurosci Ther. 2020 May;26(5):499-501. doi: 10.1111/cns.13372. Epub 2020 Apr 7.
9
Cross-reaction of Sera from COVID-19 Patients with SARS-CoV Assays.新型冠状病毒肺炎患者血清与严重急性呼吸综合征冠状病毒检测的交叉反应
Ann Acad Med Singap. 2020 Jul;49(7):523-526.
10
Rapid detection of SARS-CoV-2 in saliva: can an endodontist take the lead in point-of-care COVID-19 testing?唾液中严重急性呼吸综合征冠状病毒2的快速检测：牙髓病医生能否在即时护理新冠病毒检测中发挥带头作用？
Int Endod J. 2020 Jul;53(7):1017-1019. doi: 10.1111/iej.13317. Epub 2020 May 17.
引用本文的文献
1
The COVID-19 laboratory response in Timor-Leste; a story of collaboration.东帝汶的新冠病毒实验室应对措施；一个合作的故事。
Lancet Reg Health Southeast Asia. 2023 Apr;11:100150. doi: 10.1016/j.lansea.2023.100150. Epub 2023 Jan 13.
2
Laboratory Readiness and Response for SARS-Cov-2 in Indonesia.印度尼西亚针对 SARS-CoV-2 的实验室准备和应对。
Front Public Health. 2021 Jul 19;9:705031. doi: 10.3389/fpubh.2021.705031. eCollection 2021.
3
Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes.用于诊断和研究目的的严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）的病毒分离。
Pathology. 2020 Dec;52(7):760-763. doi: 10.1016/j.pathol.2020.09.012. Epub 2020 Oct 8.
本文引用的文献
1
Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients.基于 COVID-19 患者疾病严重程度的核酸和血清学检测结果的不同纵向模式。
Emerg Microbes Infect. 2020 Dec;9(1):833-836. doi: 10.1080/22221751.2020.1756699.
2
Temporal dynamics in viral shedding and transmissibility of COVID-19.新冠病毒脱落和传播的时间动态。
Nat Med. 2020 May;26(5):672-675. doi: 10.1038/s41591-020-0869-5. Epub 2020 Apr 15.
3
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients.严重急性呼吸综合征冠状病毒 2 特异性抗体反应在冠状病毒疾病患者中。
Emerg Infect Dis. 2020 Jul;26(7):1478-1488. doi: 10.3201/eid2607.200841. Epub 2020 Jun 21.
4
Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in Australia.从澳大利亚首例被诊断为 COVID-19 的患者中分离并快速共享 2019 年新型冠状病毒（SARS-CoV-2）。
Med J Aust. 2020 Jun;212(10):459-462. doi: 10.5694/mja2.50569. Epub 2020 Apr 1.
5
Virological assessment of hospitalized patients with COVID-2019.住院 COVID-19 患者的病毒学评估。
Nature. 2020 May;581(7809):465-469. doi: 10.1038/s41586-020-2196-x. Epub 2020 Apr 1.
6
A Genomic Perspective on the Origin and Emergence of SARS-CoV-2.从基因组角度看 SARS-CoV-2 的起源与出现。
Cell. 2020 Apr 16;181(2):223-227. doi: 10.1016/j.cell.2020.03.035. Epub 2020 Mar 26.
7
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.SARS-CoV-2 感染后口咽后唾液样本和血清抗体反应中的病毒载量时间特征：一项观察性队列研究。
Lancet Infect Dis. 2020 May;20(5):565-574. doi: 10.1016/S1473-3099(20)30196-1. Epub 2020 Mar 23.
8
Covid-19: UK government calls on industry to help boost testing capacity to 25 000 people a day.新冠疫情：英国政府呼吁企业界助力将检测能力提升至每日2.5万人。
BMJ. 2020 Mar 19;368:m1118. doi: 10.1136/bmj.m1118.
9
A Case Series of Children With 2019 Novel Coronavirus Infection: Clinical and Epidemiological Features.儿童 2019 年新型冠状病毒感染病例系列：临床和流行病学特征。
Clin Infect Dis. 2020 Sep 12;71(6):1547-1551. doi: 10.1093/cid/ciaa198.
10
Positive RT-PCR Test Results in Patients Recovered From COVID-19.新冠病毒感染者康复后出现 RT-PCR 检测结果阳性。
JAMA. 2020 Apr 21;323(15):1502-1503. doi: 10.1001/jama.2020.2783.
Zotero 插件